Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
V951A · 1 trial · 1 indication
An AE is defined as any untoward medical occurrence in a clinical database participant, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. Solicited injection-site AEs are predetermined local reactions at the injection site (such as pain/tenderness, erythema/redness, and swelling) recorded on the participant's electronic diary card.
An AE is defined as any untoward medical occurrence in a clinical database participant, temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product. Solicited systemic AEs are predetermined body-wide reactions (such as headache, fever, fatigue, myalgia/muscle pain, and arthralgia/joint pain) recorded on the participant's electronic diary card.
This measures specific body-wide side effects monitored closely (typically fever, headache, fatigue, muscle pain, and joint pain).
An AE is defined as any untoward medical occurrence in a participant, temporally associated with the use of a medicinal product, whether or not considered related. Unsolicited AEs are any unexpected, non-predetermined medical events reported by the participant that are not specifically listed on the daily diary card.
An AE is defined as any untoward medical occurrence in a participant, temporally associated with the use of a medicinal product, whether or not considered related. A Serious Adverse Event (SAE) is any AE that results in death, is life-threatening, requires or prolongs hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, or is an important medical event that may jeopardize the participant.
An AE is defined as any untoward medical occurrence in a participant, temporally associated with the use of a medicinal product, whether or not considered related. A MAAE is defined as any AE that results in an unscheduled visit to a healthcare professional (such as a physician's office, clinic, or emergency room) for medical evaluation or treatment.
An AE is defined as any untoward medical occurrence in a participant, temporally associated with the use of a medicinal product, whether or not considered related. An AESI is a noteworthy medical event of clinical interest (such as a severe allergic reaction or specific neurological event) that has been designated for expedited tracking and continuous safety surveillance within this vaccine clinical program.
| Arm | Type | Description |
|---|---|---|
| V951A Group A | EXPERIMENTAL | Healthy younger adult participants (typically aged 18 to 49) who will receive active injections of the investigational vaccine V951A. This group is evaluated to determine the vaccine's safety, tolerability, and early immune response in a younger population. |
| V951A Group B | EXPERIMENTAL | Healthy older adult participants (typically aged 50 and older) who will receive active injections of the investigational vaccine V951A. This group is evaluated to determine the vaccine's safety, tolerability, and early immune response in an older population. |
| Placebo | PLACEBO_COMPARATOR | Healthy adult participants who will receive placebo injections containing no active vaccine. This group acts as a comparator to help researchers safely evaluate the effects of the active investigational vaccine. |
| Name | Type | Description |
|---|---|---|
| V951A | BIOLOGICAL | Administered via intramuscular injection. |
| Placebo | OTHER | Administered via intramuscular injection. |
Inclusion Criteria: * Good General Health: Is in good health as determined by medical history, physical examination, vital signs, and clinical laboratory evaluations prior to study dosing. * Body Mass Index (BMI): Has a BMI within the range of 18.0 to 32.0 kg/m² (inclusive) at the time of screening...